Aortic thoracic neuromodulation in heart failure with preserved ejection fraction

The inadequacy of medical therapies for heart failure with preserved ejection fraction (HFpEF) is driving the development of device‐based solutions targeting underlying pathophysiologic abnormalities. The maladaptive autonomic imbalance with a reduction in vagal parasympathetic activity and increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Paolisso, Pasquale, Dagan, Amir, Gallinoro, Emanuele, De Colle, Cristina, Bertolone, Dario Tino, Moya, Ana, Penicka, Martin, Degrieck, Ivan, Vanderheyden, Marc, Bartunek, Jozef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871658/
https://www.ncbi.nlm.nih.gov/pubmed/36151858
http://dx.doi.org/10.1002/ehf2.14136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871658/
https://www.ncbi.nlm.nih.gov/pubmed/36151858
http://dx.doi.org/10.1002/ehf2.14136

Ejemplares similares